Fink, D; Wani, RS; Johnston, V; (2018) Fever in the returning traveller. BMJ (Clinical research ed), 360. j5773. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.j5773 Full text not available from this repository.

Post, FA; Szubert, AJ; Prendergast, AJ; Johnston, V; Lyall, H; Fitzgerald, F; Musiime, V; Musoro, G; Chepkorir, P; Agutu, C; +63 more... Mallewa, J; Rajapakse, C; Wilkes, H; Hakim, J; Mugyenyi, P; Walker, AS; Gibb, DM; Pett, SL; Reduction of EArly mortaLITY in HIV-infected adults and children; , COLLABORATORS; Gibb, D; Thomason, M; Walker, AS; Pett, S; Szubert, A; Griffiths, A; Wilkes, H; Rajapakse, C; Spyer, M; Prendergast, A; Klein, N; Looy, NV; Little, E; Fairbrother, K; Cowan, F; Seeley, J; Bernays, S; Kawuma, R; Mupambireyi, Z; Kyomuhendo, F; Nakalanzi, S; Peshu, J; Ndaa, S; Chabuka, J; Mkandawire, N; Matandika, L; Kapuya, C; Weller, I; Malianga, E; Mwansambo, C; Miiro, F; Elyanu, P; Bukusi, E; Katabira, E; Mugurungi, O; Gibb, D; Hakim, J; Etyang, A; Mugyenyi, P; Mallewa, J; Peto, T; Musoke, P; Matenga, J; Phiri, S; Lyall, H; Johnston, V; Fitzgerald, F; Post, F; Ssali, F; Prendergast, A; Arenas-Pinto, A; Turkova, A; Bamford, A; (2018) Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial. Clinical infectious diseases, 66 (suppl_2). S132-S139. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/cix1141

Stockdale, AJ; Saunders, MJ; Boyd, MA; Bonnett, LJ; Johnston, V; Wandeler, G; Schoffelen, AF; Ciaffi, L; Stafford, K; Collier, AC; +2 more... Paton, NI; Geretti, AM; (2017) Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis. Clinical infectious diseases. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/cix1108

Johnston, V; Cohen, K; Wiesner, L; Morris, L; Ledwaba, J; Fielding, KL; Charalambous, S; Churchyard, G; Phillips, A; Grant, AD; (2013) Viral suppression following switch to second-line antiretroviral therapy: associations with NRTI resistance and 'sub-therapeutic' drug concentrations prior to switch. The Journal of infectious diseases, 209 (5). pp. 711-20. ISSN 0022-1899 DOI: https://doi.org/10.1093/infdis/jit411

Johnston, V; Fielding, KL; Charalambous, S; Churchyard, G; Phillips, A; Grant, AD; (2012) Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program. Journal of acquired immune deficiency syndromes (1999), 61 (3). pp. 370-80. ISSN 1525-4135 DOI: https://doi.org/10.1097/QAI.0b013e318266ee3f

Kranzer, K; Govindasamy, D; Ford, N; Johnston, V; Lawn, SD; (2012) Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc, 15 (2). p. 17383. ISSN 1758-2652 DOI: https://doi.org/10.7448/IAS.15.2.17383